Premium
O1‐08‐01: THERAPEUTIC TARGETING OF TREM2 BY AN ACTIVATING ANTIBODY AMELIORATES AMYLOID‐BETA DEPOSITION AND IMPROVES COGNITION IN THE 5XFAD MODEL OF ALZHEIMER'S DISEASE
Author(s) -
Price Brittani R.,
Sudduth Tiffany L.,
Weekman Erica M.,
Woolums Abigail,
Hawthorne Danielle,
Rosenthal Ar,
Wilcock Donna M.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4559
Subject(s) - trem2 , microglia , medicine , alzheimer's disease , antibody , amyloid (mycology) , immunology , endocrinology , pathology , disease , inflammation
O1-07-06 PREVALENCE AND LONGITUDINAL CLINICAL OUTCOMES OFALZHEIMER’S ATN BIOMARKER PROFILES: A LONGITUDINAL STUDY Jin-Tai Yu, Jie-Qiong Li, John Suckling, Lei Feng, An Pan, Yanjiang Wang, Qiang Dong, Lan Tan, Vincent C. T. Mok, Paul S. Aisen, Michael W. Weiner, Huashan Hospital, Fudan University, Shanghai, China; Qingdao University, Qingdao, China; University of Cambridge, Cambridge, United Kingdom; National University of Singapore, Singapore, Singapore; Huazhong University of Science and Technology, Wuhan, China; Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China; Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China; Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong; Alzheimer’s Therapeutic Research Institute, San Diego, CA, USA; UCSF Department of Radiology and Biomedical Imaging, San Francisco, CA, USA. Contact e-mail: yu-jintai@ 163.com